DRUG-DRUG INTERACTIONS - A PROBLEM OF MULTIPLE DRUGS OR MULTIPLE PRESCRIBERS?

被引：0
|
作者：
Boettiger, Y.
Andersson, M.
Eiermann, B.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2014年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
217
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [21] DRUG-DRUG AND DRUG-DISEASE INTERACTIONS WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    BRATER, DC
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (1A): : 62 - 77
  • [22] Drug-Drug Interactions: An Under-Estimated Problem
    Ponte, M. L.
    Carrara, R.
    Flores Lazdin, C.
    Wachs, A.
    DRUG SAFETY, 2010, 33 (10) : 894 - 894
  • [23] Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge
    Ko, Yu
    Malone, Daniel C.
    D'Agostino, Jerome V.
    Skrepnek, Grant H.
    Armstrong, Edward P.
    Brown, Mary
    Woosley, Raymond L.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2008, 4 (04): : 355 - 366
  • [24] Prevalence of drug-drug interactions with psychiatric drugs in a HIV-infected community: a real problem
    Romeromartin, C.
    Padilla Romero, P.
    Lopez-Arteaga, T.
    Perez Castellano, M. T.
    EUROPEAN PSYCHIATRY, 2019, 56 : S479 - S479
  • [25] In vitro-to-in vivo predictions of drug-drug interactions involving multiple reversible inhibitors
    Lutz, Justin D.
    Isoherranen, Nina
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (04) : 449 - 466
  • [26] Multiple drugsVarious toxicities, drug-drug interactions and medication errors: 43 case reports
    Reactions Weekly, 2022, 1899 (1) : 289 - 289
  • [27] Multiple drugsVisual hallucinations following drug-drug interactions and lack of efficacy: case report
    Reactions Weekly, 2023, 1965 (1) : 376 - 376
  • [28] Evaluating the Impact of polypharmacy and drug-drug interactions on Cognitive performance of Multiple Sclerosis patients
    Jahani, Shima
    Rezaei, Ali
    Hamidi, Majid
    Moghadasi, Abdorreza Naser
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1044 - 1044
  • [29] Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
    Bachmann, Paula
    Frahm, Niklas
    Debus, Jane Louisa
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Streckenbach, Barbara
    Baldt, Julia
    Heidler, Felicita
    Hecker, Michael
    Zettl, Uwe Klaus
    PHARMACEUTICS, 2022, 14 (03)
  • [30] The risk of polypharmacy, comorbidities and drug-drug interactions in women of childbearing age with multiple sclerosis
    Frahm, Niklas
    Hecker, Michael
    Langhorst, Silvan Elias
    Mashhadiakbar, Pegah
    Haker, Marie-Celine
    Zettl, Uwe Klaus
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
12345